Endogenous anti-β-glucan antibodies as a potential predictive biomarker for clinical response to imprime PGG immunotherapy in non-small cell lung cancer (NSCLC) patients
Bose, Nandita, Antonysamy, Mary, Patchen, Myra Louise, Lowe, Jamie R., Mattson, Paulette, Gargano, Michele Anne, Gorden, Keith, Leonardo, Steven, Walsh, Richard, Qui, Xiaohong, Ottoson, Nadine, Ertelt, Katie E., Wurst, Lindsay R., McMurray, Diane, Chan, Anissa S.H., Jonas, Adria, Huhn, Richard Dale, Thomas, Michael, Sadjadian, Parvis, Schneller, Folker
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article